Tilray | TRLY - Market Capitalization



Tilray reported CAD1.23B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Alaunos Therapeutics USD 3M 2M Dec/2024
Aurora Cannabis CAD 405.84M 81.86M Sep/2025
Avita Medical AUD 335.59M 29.1M Dec/2024
Canopy Growth CAD 225.05M 88.93M Sep/2025
Cronos Group CAD 739.79M 258.41M Jun/2025
Dianthus Therapeutics USD 692M 93M Sep/2025
Divis Laboratories Ltd 1.81T 277.71B Jun/2025
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
IQVIA Holdings USD 27.26B 3.82B Jun/2025
Knight Therapeutics CAD 599.03M 24.75M Sep/2024
Moderna USD 10.67B 290M Jun/2025
Organigram Holdings CAD 222.95M 23.4M Sep/2025
Organon & Co USD 2.41B 108.26M Sep/2025
Revvity USD 11.53B 1.18B Jun/2025
Tectonic Therapeutic USD 377M 6M Sep/2025
Tilray CAD 647.69M 211.12M Aug/2025
Viatris USD 10.48B 83.95M Jun/2025
Xeris Pharmaceuticals USD 1.1B 347M Sep/2025